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Abstract Every year, seasonal epidemics of influenza viruses are causing considerable
morbidity and mortality worldwide. Also infrequent novel and rearranged strains of influ-
enza viruses have caused quick, acute universal pandemics resulting in millions of mortal-
ities. The usage of efficient and accurate detection is superior for infection control, effective
treatment, and epidemiological supervision. Therefore, evaluation of useful real-time PCR
molecular tests for the detection of pandemic viruses is important before the next wave of the
pandemic. A novel quantitative real-time reverse-transcription polymerase chain reaction
(qRT-PCR) assay with specific primers was used successfully for detection and monitoring
of the influenza A, B, and swine influenza. The newly designed primers target highly
conserved regions in influenza viruses. Our qRT-PCR assay is highly specific for detecting
influenza A, B, and swine influenza viruses. The cutoff CT value was determined <38 for
domestic human diagnostic test, under conditions of FDA emergency, and the reaction
efficiency of the InfA, swInfA, and InfB assays were thereby estimated to be 97.9 %
(R2=0.998), 98.3 % (R2=0.986), and 99.5 % (R2=0.995), respectively. Interestingly, based
on our finding, there is no cross reactivity of detecting other viruses.
Keywords Influenza A . Influenza B . Swine influenza . rRT-PCR . Real-time PCR
Introduction
Influenza A and B viruses cause the majority of viral lower respiratory tract infections;
elderly and compromised individuals are especially at risk of developing severe illness and
complications [1, 2].
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In April 2009, novel swine-lineage influenza A (H1N1 swl) virus entered the human
population and spread rapidly throughout the world [1]. Subsequent phylogenetic charac-
terization of this swine origin influenza virus A (H1N1 swl) from the US index case
indicated that the virus had a unique genome composition that had not been previously
reported [1, 2].
For virus isolation such as cell culture, shell vial culturing, serologic analysis, and antigen
detection are the conventional methods used for the laboratory diagnosis of influenza
viruses. Although these methods have their limitations such as virus isolation via cell
culturing that is a labor-intensive and time-consuming method despite its sensitivity [3].
On the other hand, other diagnostic techniques, for example antigen detection and shell vial
culturing, provide results more quickly but typically are less sensitive than conventional cell
culturing or PCR [4–6].
To obtain far more rapid diagnostic results and to overcome this lack of sensitivity, PCR
techniques have been developed for the specific detection and subtyping of influenza viruses
[7].
The emergence of the SWL H1N1 has ramifications for existing typing and diagnostic
PCR methods and may result in a failure to detect and/or type this new virus because of the
genetic differences mentioned above [2].
As all influenza virus subtypes causes similar clinical symptoms, differential diagno-
sis of the virus is required in one sample. Mono-specific PCR tests require separate
amplification of each amplicon and are therefore time consuming and resource inten-
sive. Multiplex PCR for clinical diagnosis has a major advantage, as it permits
simultaneous amplification of several pathogens in a single reaction tube, providing
cost-effective diagnosis [8–10]. However, so far, these multiplex PCR assays distinguish
the target by PCR amplicon size on electrophoresis or hybridization with probes post-
PCR.
Real-time PCR with specific detection of the product by fluorophore probes increases
the specificity of tests and significantly reduces processing time. In addition, another
feature of the real-time PCR method is the ability to perform multiplex amplification
and detection [11, 12].
This study describes the development and use of a multiplex real-time RT-PCR assay
as a diagnostic tool for the cost effective, simultaneous, and fast diagnosis of influenza
A, B, and swine origin influenza A (H1N1) viruses specifically to diagnose influenza
virus strains in Iran.
Material and Methods
Virus Strains and Viral RNA Preparation
In this study, influenza viruses were grown to high titers in either Madin–Darby canine
kidney cells or embryonated chicken eggs. Infectious viruses in culture supernatants or
allantoic fluids was measured by determining the number of 50 % tissue culture infectious
doses per milliliter or the number of 50 % egg infectious doses per milliliter, respectively.
Clinical specimens (nasal washes, nasal swabs, nasopharyngeal swabs, throat swabs, and
lower respiratory tract specimens) included in this study were received from Tehran,
different cities in Iran, and other local public health laboratories as well as foreign labora-
tories between April 2011 and June 2012.
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RNA Extraction
Viral RNAwas extracted from 100 ul virus isolates or clinical specimens and eluted in 100 ul
volumes by using viral RNA isolation kit (Bioneer, Korea), according to the manufacturer’s
instructions.
rRT-PCR Flu Panel Primers and Probes
Oligonucleotide primers and probes were designed based on available nucleotide sequence data
from the GenBank database of the National Center for Biotechnology Information (NCBI),
NIH, the influenza sequence database of Los Alamos National Laboratories, and the Global
Initiative on Sharing Avian Influenza Data. Nucleotide BLAST search (NCBI) analysis was
used to verify primer and probe sequence specificity and avoid potential nonspecific reactivity.
The primers and probes were designed to have annealing temperatures of approximately 60 and
62 °C, respectively, using Beacon designer software ver. 8 (Primer Biosoft, USA). Dual-labeled
hydrolysis probes were labeled at the 5' end with the reporter dye (FAM, Hex, Texasred, cyc5)
and quenched with Black Hole Quencher 1 either at the 3' end or internally at a modified “T”
residue with Spacer3 (3'Sp3) at the 3' end to prevent probe extension by Taq polymerase
(Metabion international AG, Germany). Primers and dually labeled TaqMan hydrolysis probes
were synthesized by Metabion international AG, Inc. (Germany, Munich). The rRT-PCR flu
panel includes four sets of oligonucleotide primer and probe (universal influenza A (InfA),
swine influenza A (swInfA), influenza B, and RNase P (RP)) designed for the detection and
characterization of influenza A, swine influenza A, and influenza B viruses in human speci-
mens. The InfA assay was designed for universal detection of the matrix (M) gene of all
influenza A viruses. The InfB assay was designed for universal detection of the nucleoprotein
gene of influenza B gene of all influenza B viruses.
The RP assay detects the human RNase P gene and used for human clinical specimens to
measure the quality of nucleic acid extraction to indicate that the gene was adequately
extracted from the clinical specimen (Table 1).
Table 1 Sequence primers and probes
Primers and probes Sequence (5′>3′)
Influenza A–forward CAT GGA ATG GCT AAA GAC AAG
Influenza A–reverse CCA TTT AGG GCATTT TGG ACA
Influenza A–probe TTT GTG TTYACG CTC ACC GTG CC
Influenza SwH1–forward GTG CTA TAA ACA CCA GCC TYC CAA
Influenza SwH1–reverse CGG GAT ATT CCT TAA TCC TGT RGC
Influenza SwH1–probe CA GAATAT ACA “T”CC RGT CAC AAT TGG ARA*
RNaseP–forward AGATTT GGA CCT GCG AGC
RNaseP–reverse GAG CGG CTG TCT CCA CAA G
RNaseP–probe TTC TGA CCT GAA GGC TCT GCG C
Influenza B–forward AGA CCA GAG GGA AAC TAT GCC C
Influenza B–reverse TCC GGATGT AAC AGG TCT GAC TT
Influenza B–probe ACC TTC GGC AAA AGC TTC AAT ACT CCA
*Taqman probes are labeled at the 5′-end with the reporter molecule and quenched internally at a modified “T”
residue, with a modified 3′-end to prevent probe extension by Taq polymerase
Appl Biochem Biotechnol
rRT-PCR Conditions
Reaction’s conditions for rRT-PCR were based on the Food and Drug Administration
(FDA)-cleared CDC human influenza virus real-time RT-PCR detection and characterization
panel (CDC rRT-PCR Flu Panel). The CDC rRT-PCR Flu Panel contains the same set of
primer and probe for detection of the influenza A virus matrix gene similar to the CDC rRT-
PCR Swine Flu Panel.
In order to determine the optimal annealing and extension temperatures, thermal gradient
analysis was performed in triplicate using the Rotor-Gene 6000 system (Corbett
research,Australia) and the RNA extracted from 2008 (H1N1) influenza A virus strain
A/Tehran/2008/H1N1, A/Iran/14068/2009/H1N1, A/shiraz/15/2005/H1N1 for detection in-
fluenza A/SW and influenza B/Tehran/12/2007 virus for influenza B. Thermocycling rRT-
PCR conditions were 42 °C for 30 min, Taq activation for 7 min at 95 °C, and 45 cycles of
95 °C for 15 s and an annealing extension step with temperatures ranging from 50 to 65 °C
for 30 s. All three assays showed comparable levels of performance, with annealing
temperatures ranging from 58 to 60 °C. The final reaction annealing temperature was set
to 60 °C, which is 5 °C below the maximum optimal annealing temperature (65 °C) used to
accommodate potential nucleotide mismatches in the primer–probe regions due to virus
evolution (Table 2).
PCR parameters of the rRT-PCR flu panel were optimized using Real Master mix RT-
PCR probe kits (5 Prime Technologies) and Rotor-Gene 6000 system (Corbett research,
Australia) real-time PCR system. All rRT-PCRs were performed at total reaction volume of
25 ul. Final primer and probe reaction concentrations were 0.5 and 0.2 uM, respectively. All
analytical performance data and clinical specimen data were collected using a Rotor Gene
6000 software real-time PCR instrument.
Table 2 Determination of opti-
mal annealing temperature
aValues represents mean Ct
values ± SD (n=3) of the results
with annealing temperature
ranging from 50 to 65 °C
Ct value for indicated assay a
Annealing temperature(°C) InfluA SWInfluA InfluB
50 °C 22.2±0.2 18.6±0.3 22.3±0.4
51 °C 23.1±0.3 18.9±0.5 23.2±0.5
52 °C 21.2±0.4 19.1±0.8 24.3±0.6
53 °C 25.3±0.2 19.6±0.7 25.2±0.9
54 °C 26.6±0.3 20.1±0.6 23.1±0.8
55 °C 20.3±0.2 20.6±0.6 19.5±0.6
56 °C 23.2±0.1 19.6±0.3 19.8±0.5
57 °C 18.6±0.6 20.2±0.2 20.2±0.4
58 °C 19.2±0.1 22.3±0.1 22.3±0.4
59 °C 18.2±0.3 24.2±0.4 23.4±0.3
60 °C 17.9±0.2 16.1±0.4 18.6±0.1
61 °C 19.3±0.4 19.3±0.1 18.9±0.3
62 °C 20.3±0.3 18.5±0.3 21.3±0.5
63 °C 23.2±0.7 20.3±0.7 22.2±0.7
64 °C 25.2±0.3 21.5±0.8 21.3±0.5
65 °C 23.1±0.2 22.4±0.9 24.1±0.1
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Results
rRT-PCR Flu Panel Reaction Efficiency
Reaction’s efficiency for primer and probe contained sets of InfA, swInfA, and InfB
assays which were determined by testing a fivefold serial dilution series of viral RNA
of 2008 A (H1N1) influenza virus strain A/Tehran/2008, A/Iran/14068/2009/H1N1,
A/shiraz/15/2005/H1N1, and influenza B/Tehran/12/2007 virus for InfB duplicated.
The resulting threshold cycle (CT) values were plotted versus relative RNA concen-
tration values, and linear regression analysis was applied to determine the slopes. The
reaction efficiency of the InfA, swInfA, and InfB assays were thereby estimated as
97.9 % (R2=0.998), 98.3 % (R2=0.986), and 99.5 % (R2=0.995), respectively (data
not shown).
Analytical Sensitivity
The limits of detection (LoD) of the InfA, swInfA, and InfB assays were determined by
analyzing a tenfold dilution series of grown influenza viruses (influenza A virus strain
A/Tehran/2008/H1N1, A/Iran/14068/2009/H1N1, A/shiraz/15/2005/H1N1 for detection in-
fluenza A/SW, and influenza B/Tehran/12/2007 virus) (Influenza Lab center, Tehran, Iran).
A tenfold dilution series were tested in triplicate for each extracted virus strain (Table 3). The
LoD of the rRT-PCR flu panel was determined according to the lowest concentration at
which all three assays (InfA, swInfA, InfB) gave positive results. The LoD was determined
between 101 and 101.5 ID50/ml virus concentrations to test three viruses. Similarly,
quantified synthetic RNA of viruses was tested in duplicate with a commercial real-
time PCR kit (ILS, Inter Lab Service, Russia) to determine the detectable minimum
RNA copy number assay. The LoD of the InfA, swInfA, and InfB assays were found
in 12 copies of RNA per reaction. The cutoff CT value for the flu panel was
determined <38 for domestic human diagnostic test, under conditions of FDA
Emergency Use Authorization in the US. This cutoff value is based upon the data
from LoD analysis that are consistent with the cutoff value of <38 previously
established for the rRT-PCR flu panel (Table 4).
Analytical Specificity and Inclusivity
Assay specificity was showed by testing four strains of influenza A (H1N1) viruses
from Iranian population. Viruses were diluted approximately tenfold above the limit of
detection of the assay, and the extracted RNA was tested in triplicate. Average Ct
values for commercial kit and the rRT-PCR flu panel was compromised. As expected,
all four viruses tested positive in the InfA, swInfA, and InfB assays at low virus
concentrations (Table 5). All test results were 100 % concordant with the expected
results.
Analytical Specificity and Exclusivity
In order to demonstrate the absence of cross-reactivity with other common human
respiratory pathogens, exclusivity testing was performed by examining 34 non-
influenza virus strains and bacterial organisms commonly present in the nasopharynx
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region of the human respiratory tract. Cross-reactivity was not observed in any of the
non-influenza organisms which were tested at high titers. Extracted RNA from non-
SW animal influenza viruses were also tested at high virus titers. As expected, all
non-SW animal influenza viruses were InfA positive and swH1 negative, although
some viruses were positive in the swInfA assay. Interestingly, not all three assays
were positive for any non-SW animal influenza virus, so these results would be
considered inconclusive and require further testing.
Table 3 Assay limit of detection (LoD) in three influenza A virus strains and influenza B virus
Influenza virus and copies/ml InfluA rRT-PCR results InfluSW InfluB LoD
A/Tehran/2008/H1N1 +/+/+ +/+/+ −/−/− 101.5
106 +/+/+ +/+/+ −/−/−
105.5 +/+/+ +/+/+ −/−/−
104.5 +/+/+ +/+/+ −/−/−
103.5 +/+/+ +/+/+ −/−/−
102.5 +/+/+ +/+/+ −/−/−
101.5 +/+/+ +/+/+ −/−/−
101 −/−/− −/−/− −/−/−
10−1 −/−/− −/−/− −/−/−
A/Iran/14068/2009/H1N1 +/+/+ +/+/+ −/−/− 101.6
106.6 +/+/+ +/+/+ −/−/−
105.6 +/+/+ +/+/+ −/−/−
104.6 +/+/+ +/+/+ −/−/−
103.6 +/+/+ +/+/+ −/−/−
102.6 +/+/+ +/+/+ −/−/−
101.6 +/+/+ +/+/+ −/−/−
100.6 −/−/− −/−/− −/−/−
10−0.6 −/−/− −/−/− −/−/−
A/shiraz/15/2005/H1N1 +/+/+ +/+/+ −/−/− 101.2
106.2 +/+/+ +/+/+ −/−/−
105.2 +/+/+ +/+/+ −/−/−
104.2 +/+/+ +/+/+ −/−/−
103.2 +/+/+ +/+/+ −/−/−
102.2 +/+/+ +/+/+ −/−/−
101.2 +/+/+ +/+/+ −/−/−
100.2 −/−/− −/−/− −/−/−
10−1 −/−/− −/−/− −/−/−
B/Tehran/12/2007 −/−/− −/−/− +/+/+ 101
105 −/−/− −/−/− +/+/+
104 −/−/− −/−/− +/+/+
103 −/−/− −/−/− +/+/+
102 −/−/− −/−/− +/+/+
101 −/−/− −/−/− +/+/+
10−1 −/−/− −/−/− −/−/−
+ Positive rRT-PCR result; − negative rRT-PCR result
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Discussion
We report the development of a multiplex RT-PCR to rapidly detect and subtype all currently
circulating strains of human influenza virus in Iran, including influenza A, B, and swine origin
influenza A (H1N1) virus.
Only a few assays that are capable of subtyping human and animal influenza viruses have
been developed. One of these assays focuses specifically on swine influenza viruses and can
detect and differentiate the H1, H3, N1, and N2 genes from currently circulating strains [13].
The primers from this multiplex assay appear to be capable of detecting swine origin
influenza (S-OIV) H1 and N1 genes but are not likely to be capable of detecting the H1
gene of human viruses. Additionally, this study was designed to test swine specimens and
may not be proper for human samples. A group of similar methods are capable of detecting
H1 to H12 and N1 to N9 subtypes of the virus. These systems consist of five multiplex
reactions (three of which are capable of detecting four different HA subtypes and two of
them can each detect two different NA subtypes). The authors presenting these assays
describe that they are capable of detecting human, avian, and swine viruses [14]. All of
these methods subtype viruses by product size as visualized on an agarose gel [9, 10, 13].
In comparison, conventional PCR assays use gel electrophoresis, blotting, or hybridiza-
tion to detect the amplified targets and take significantly more hands-on time [9]. The
multiplex real-time PCR provides us a diagnostic result within one working day and
eliminates post-PCR processing besides reducing the risk of cross-contamination.
Table 5 Comparison analytical specificity between commercial kit and rRT-PCR flu panel
Average Ct value commercial kit/flu panel
Influenza virus Copies/ml InfluA InfluSW InfluB
A/Tehran/2008/H1N1 19 38.6/34.2 37.3/33.5 −/−
A/Iran/14068/2009/H1N1 15 36.2/32.5 35.6/31.6 −/−
A/shiraz/15/2005/H1N1 17 37.4/33.5 36.5/32.6 −/−
A/Tehran/5675/2010/H1N1 18 38.1/34.8 37.6/33.7 −/−
B/Tehran/12/2007 15 −/− −/− 37.1/35.3
B/Tehran/8/02 18 −/− −/− 35.3/32.6
Table 4 Assay limit of detection
determined using rRT-PCR flu
panel
Ct values for duplicate assay(duplicate)
No. of virus (copies/ml) InfA Inf SW H1N1 InfB
1,000,000 17.6/17.3 17.8/17.6 18.6/18.2
100,000 23.4/23.6 23.6/23.8 24.6/24.8
10,000 26.3/26.5 26.5/26.4 28.3/28.2
1,000 30.5/30.4 30.5/30.8 31.2/31.5
100 32.6/32.5 32.3/32.6 33.4/33.5
10 35.6/35.8 35.6/35.8 36.2/36.7
1 −/− −/− −/−
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Multiplex real-time PCR was found to be more sensitive than cell culture on a range of
different respiratory samples. These findings are consistent with those of other studies,
which employed RT-PCR for the detection of viral infections [15–17].
Our findings demonstrate that the multiplex TaqMan PCR is a sensitive and specific
method for the simultaneous rapid detection of influenza viruses A, B, and swine-lineage
influenza A. In the design of these real-time PCRs, an alignment of conserved regions of the
target viruses was made with publicly available GenBank sequences. The detection limit of
the multiplex real-time PCR method was measured by using tenfold serial dilution series of
viral RNA of three different flu panel. The limit of detection of InfA, swInfA, and InfB
assays were found in 12 copies of RNA per reaction. The cutoff CT value for the flu panel
was determined <38, and regardless of the method chosen for sensitivity determination, it is
difficult to ascertain the minimum number of target viruses needed for a detectable PCR
product.
The analytical specificity of our multiplex real-time PCR assay was tested, and we
detected no cross-reactivity between influenza viruses A/Tehran/2008/H1N1,
A/shiraz/15/2005/H1N1, and B/Tehran/12/2007 or B/Tehran/8/02.
As demonstrated in this study, it is often difficult to achieve both high sensitivity and high
specificity for viral nucleic acid detection. The primer–probe sets SwH1 (Table 2) are highly
sensitive (ten copies/ml) but react nonspecifically with other influenza A subtypes (Table 3).
In summary, we have developed a rapid multiplex real-time PCR assay with the ability to
accurately detect and differentiate influenza A, influenza B, and swine origin influenza A
(H1N1) virus and this multiplex real-time PCR assay constitutes a specific and sensitive
alternative to conventional culture and IF methods, and use of this assay would aid in the
diagnosis of respiratory disease. Specific and sensitive results within 6 h are important in a
clinical setting, and therefore, this assay could improve patient management by appropriate
therapy following rapid diagnosis of a viral infection.
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